Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Open Label Trial of Ranolazine in Myotonia Congenita, Paramyotonia Congenita, & Myotonic Dystrophy Type 1

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02251457
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:23.206813+00:00
Published At
2019-03-05T00:00:00+00:00
Record Updated At
2019-03-05
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Myotonia Congenita", "Paramyotonia Congenita", "Myotonic Dystrophy 1"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2019-03-05"
protocolSection.identificationModule.nctId
"NCT02251457"
protocolSection.identificationModule.officialTitle
"Open Label Trial of Ranolazine in Myotonia Congenita, Paramyotonia Congenita, \u0026 Myotonic Dystrophy Type 1"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Myotonia Congenita (protocolSection.conditionsModule.conditions)
  • Paramyotonia Congenita (protocolSection.conditionsModule.conditions)
  • Myotonic Dystrophy 1 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.